trending Market Intelligence /marketintelligence/en/news-insights/trending/rmuyyq3hxcfvgxf2cchdsw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Processa Pharmaceuticals appoints CFO

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Processa Pharmaceuticals appoints CFO

Processa Pharmaceuticals Inc. appointed James Stanker as its CFO.

The Hanover, Md.-based company said Stanker brings more than 25 years of financial and executive leadership experience to Processa in the areas of accounting principles and audit standards, regulatory reporting and fiscal management and strategy.

Processa Pharmaceuticals is developing a medicine for a skin condition known as necrobiosis lipoidica.